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The purpose of this study is to describe our initial experience with embolization of pulmonary arteriovenous
malformations (PAVMs) using hydrogel microcoils. The technical and radiological outcomes were retrospectively
reviewed in seven patients with nine simple-type PAVMs (median feeder size 4 mm, range 3-6 mm) who underwent
embolization. Hydrogel microcoils were mainly used, and detachable bare microcoils were combined as needed to
occlude the terminal feeding artery just before the sac. Of a total of 43 microcoils, 30 (69.8%) hydrogel microcoils
were deployed in eight PAVMs with the median number 3.5 (range 2 to 6) per lesion. All hydrogel microcoils were
successfully deployed without microcatheter stuck or malposition. In the remaining one small PAVM, only soft bare
microcoils were used, however, resulting in recanalization requiring additional coils in the second session. The
venous sac was substantially shrunk in all lesions treated with hydrogel microcoils with the median size reduction
rate 95.0% (range 81.8% to 99.0%) during the median follow-up period 10 months (range 6 to 18 months). In
conclusion, hydrogel microcoils were safely and effectively applied for occluding PAVMs with relatively small feeders.
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Pulmonary arteriovenous malformations (PAVMs) are
abnormal fistulous connections between pulmonary ar-
teries and veins forming a venous sac. PAVMs occur
either sporadically or as a part of manifestations of her-
editary hemorrhagic telangiectasia (HHT). The patients
may suffer from stroke or brain abscess due to paradox-
ical embolism, dyspnea and fatigue due to hypoxemia,
and rarely, hemoptysis or hemothorax due to spontan-
eous rupture of the venous sac. According to the inter-
national guidelines for the diagnosis and management of
HHT, transcatheter embolization is the first-line treat-
ment for symptomatic PAVMs (Faughnan et al. 2011).
For asymptomatic PAVMs, the feeding artery 3 mm or
greater in diameter is generally considered as the size
threshold for embolization, although embolization can
be also performed in smaller feeding arteries. Although* Correspondence: osuga@radiol.med.osaka-u.ac.jp
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in any medium, provided the original work is pefficacy and safety of coil embolization has been demon-
strated in mostly case series, reperfusion of treated
PAVMs mainly occur due to recanalization through
the coils (Pollak et al. 2006). Therefore, it is important
to increase the coil packing density to achieve high de-
gree of cross-sectional occlusion for long-term occlusion
(Pollak et al. 2006).
Recently, hydrogel coated detachable microcoils or
hydrogel microcoils (Azur, Terumo, Tokyo, Japan) has
been introduced for peripheral coil embolization (Nambiar
et al. 2008). The hydrogel microcoils are coated with poly-
mer that expand in contact with blood, and thus, have an
advantage of greater filling volume compared with bare
platinum coils. Although hydrogel microcoils theoretically
lower the risk of recanalization, there have been few re-
ports to describe details of their application in PAVM
embolization. Therefore, the feasibility or role of hydrogel
microcoils in this particular indication remains unclear. In
this report, we describe our initial experience with use of
hydrogel microcoils in a series of patients with PAVMs
with relatively small feeding arteries.n Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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Patients
We retrospectively reviewed the medical records and
radiological findings of seven consecutive patients with a
total of nine PAVMs who underwent embolization mainly
using hydrogel microcoils between December 2012 and
June 2013. All patients were female, and the mean age was
57.9 years old (range 24 - 69). One patient had hereditary
hemorrhagic telangiectasia (HHT), according to the Cura-
çao’s clinical diagnostic criteria (Shovlin et al. 2000). Six
patients had a single PAVM, and one patient had three
PAVMs. Four patients had past histories of neurological
complications including brain infarction due to paradox-
ical embolism (n = 3) and spinal hemorrhage from spinal
AVM (n = 1). All nine lesions consisted of a simple AV fis-
tula with a single feeder and a single drainer. These feed-
ing arteries were relatively small with the median diameter
of 4 mm (range 3-6 mm). The median maximum size of
venous sac was 13.5 mm (range 3 to 17 mm). Room air
oxygen saturation was >95% in all patients, and none of
them showed hypoxic symptoms. The indication for coil
embolization included i) past history of paradoxical em-
bolism (n = 3), ii) feeder size 3 mm or larger (n = 7), and/
or iii) multiplicity (n = 1), that were considered as the fur-
ther risks of paradoxical embolism. The written informed
consent was obtained from in all patients, and this retro-
spective study was approved by the internal review board.
Coils
Hydrogel microcoils are 0.018-inch detachable platinum
microcoils coated with hydrogel polymer that expand
when the polymer contact with blood. The hydrogel ex-
pands approximately five times the original volume of
the bare coil, thus may offer more filling volume with
potentially fewer number of microcoils. The available
coil size were 3 mm, 4 mm, 5 mm, 6 mm, and 8 mm in
loop diameter and 5 cm, 10 cm, and 20 cm in the ex-
tended length. The hydrogel microcoils were prepared
and deployed according to the manufacturer’s instruc-
tion. For pre-softening, the stretched hydrogel microcoil
was immersed in warm sterile saline at 60 degree C in
five to ten seconds until the coil curls. When the hydro-
gel microcoil was appropriately positioned in the vessel,
the coil was released with a detachment controller (V-
Grip, Terumo, Tokyo, Japan). Repositioning time of the
coil was limited within three minutes from the time of
loading into the microcatheter, because it will become
difficult to retract the coil once in contact with blood. It
will take approximately 20 minutes until complete ex-
pansion of the hydrogel.
Embolization procedures
All procedures were performed under local anesthesia. A
6Fr introducer sheath was inserted via the right femoralvein in six patients and via the right jugular vein in one
patient because of lower leg paralysis and atrophy as a
sequel of spinal hemorrhage. Diagnostic pulmonary
angiography was performed using a 4Fr pigtail catheter
sequentially to each lung to identify all lesions and their
feeding arteries. Then, the pigtail catheter was ex-
changed to a coaxial guiding catheter systems (Medikit,
Tokyo, Japan) consisting of an outer 6Fr multipurpose
guiding catheter and an inner 4Fr catheter with a short
distal angle. Following the selective insertion of the inner
coaxial catheter into the feeding artery, the outer guiding
catheter was advanced over it to provide adequate sup-
port for coil deployment maneuvers. When the coaxial
guiding catheter system was settled, a 2.0Fr two-marker
microcatheter with inner diameter 0.022 inch (Pro-
greatβ3, Terumo, Tokyo, Japan) was coaxially advanced
in the distal feeding artery as close to the venous sac as
possible. As a rule, the terminal segment of the feeding
artery beyond any significant normal branches was oc-
cluded with mainly hydrogel microcoils. Because of the
limited reposition time of the hydrogel microcoil within
three minutes, the attending nurse measured the time
from the coil loading into the microcatheter, and called
how much time was left per minute to complete the coil
deployment. Softer bare platinum detachable microcoils
(Helipaq or Cashmere, Codman & Shurtleff, Raynham,
MA, USA) were combined as needed. For the first coil,
an oversized coil was deployed to avoid coil migration
into the pulmonary vein. If there was a small distal nor-
mal branch near the venous sac, the anchor technique
was applied to secure the coil stability, where the initial
few centimeters of the coil was hooked in the side
branch and the rest of the coil was released in the feed-
ing artery. Once the first coil was settled, hydrogel
microcoils were mainly used for the filling of the feeding
artery until the blood flow substantially reduced by test
injection of contrast media. The hand injection angiog-
raphy was sequentially obtained 10 minutes and 20 mi-
nutes after the last hydrogel microcoil was deployed. If
there was residual blood flow even after 20 minutes,
additional hydrogel coils or softer bare platinum micro-
coils were deployed as needed. Finally, adequate occlu-
sion of the feeding artery was confirmed by the main
pulmonary angiography, and it was also assessed if any
accessory feeding artery was missed. Technical success
was defined as complete occlusion of the targeted le-
sions at the end of procedure.
During the procedure, patients received prophylactic an-
tibiotics with 1 g of intravenous cefazolin sodium. They
also received 3,000 – 5,000 U of intravenous heparin to
maintain the activated clotting time (ACT) beyond
200 seconds to avoid the thrombi formation around the
catheters and coils that could cause paradoxical embolism
before the complete occlusion was achieved.
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Follow-up CT scans using 64-channel multi-detector CT
scanners (LightSpeed VCT, GE Healthcare, Milwaukee,
WI, USA) were performed between 6 months and
18 months after the procedure to evaluate the shrinkage
of venous sac and any coil-associated complication. The
whole lung non-contrast CT images were obtained with
a 0.625 mm collimation and 1.375 pitch. Efficacy of
embolotherapy was assessed by the bi-dimensional size
reduction rate of the venous sac at its longest diameter
on the follow-up axial CT images in the lung window
setting. The measurement of the venous sac was per-
formed by consensus of the two board-certified diagnos-
tic radiologists from authors.
Results
All embolization procedures were successfully completed.
The technical and radiological results are summarized in
Table 1. Of a total of 43 microcoils, 30 (69.8%) hyrdogel
microcoils were deployed in eight PAVMs with the median
number 3.5 (range 2 to 6) per lesion. All hydrogel micro-
coils were deployed within one to two minutes. Neither
coil stuck in the microcatheter, malposition in the target
vessel, nor migration into non-target vessels occurred. Ex-
ceptionally, in one small PAVM, only soft bare platinum
microcoils were deployed because of the microcatheter in-
stability in the small and tortuous feeding artery (Case 6,
lesion no. 8). In five PAVMs, oversized bare platinum
microcoils were combined for the first one or two coils to
create a scaffold for the following hydrogel microcoils. In
two PAVMs, small softer bare platinum microcoils were
added proximal to the hydrogel microcoils. The ratio of
number of hydrogel microcoils per total number of coils
ranged from 42.9% to 100% with the median 70.9%. The
ratio of total length of hydrogel microcoils per the total
length of all coils ranged from 41.7% to 100% with the me-














1-1 6 6 / 6 (100) 60 (100) 8-3
2-2 5 4 / 6 (66.7) 40 (42.5) 6-3
3-3 3 3 / 4 (75.0) 25 (55.6) 4-3
4-4 4 5 / 5 (100) 60 (100) 6-3
5-5 3 2 / 3 (66.7) 40 (66.7) 4
6-6 4 3 / 7 (42.9) 60 (75.0) 6-4
6-7 3 3 / 7 (42.9) 30 (41.7) 4-3
6-8* 3 0 / 10 (0) 0 / 56 (0) NA
7-9 5 4 / 5 (80) 60 (66.7) 4-3
* Only bare microcoils were used in two sessions. NA: not applicable.10 minutes in two lesions (25%), and at 20 minutes at
three lesions (37.5%) (Figure 1). In the remaining three
PAVMs (37.5%), additional hydrogel microcoils (n = 2) or
softer bare platinum microcoils (n = 1) were added be-
cause of incomplete occlusion at 20 minutes.
In one patient with three PAVMs, the two lesions of
the left lung and the one lesion of the right lung were
treated in two separate sessions with two-months inter-
val. In the second session, the left pulmonary angiog-
raphy revealed that the lesion treated by hydrogel
microcoils was completely occluded, whereas the other
smaller lesion treated by bare microcoils alone showed
recanalization of the feeding artery through the coil in-
terstices (Figure 2). Therefore, small bare platinum
microcoils were added proximal to the previous coils.
The venous sac was substantially shrunk in all PAVMs
treated with hydrogel coils. The median size reduction
rate of venous sac was 95.0% (range 81.8 to 99.0%) dur-
ing the median follow-up period 10 months (range 6 to
18 months). During the follow-up, no minor or major
complication was observed in all patients.
Discussion
Transcatheter embolization has been the treatment of
choice for occluding PAVMs. Fibered pushable coils have
been widely used for the mechanical occlusion of feeding
arteries (Pollak et al. 2006). Recently, the Amplatzer vas-
cular plug (AVP) family has been also introduced to oc-
clude large feeders safely with a single device or in
combination with coils (Trerotola & Pyeritz 2010). On the
other hand, the advance in microcoils and microcatheter
technology has enabled selective embolization of small or
tortuous vessels, where insertion of the regular delivery
catheters is considered difficult or harmful. Especially, soft
detachable microcoils, although they are expensive, have
been increasingly applied in PAVM embolization, because








14 × 10 7 × 1 12 95.0
17 × 10 4 × 2 6 95.3
3 × 3 1 × 1 6 88.9
16 × 12 2 × 1 6 99.0
14 × 9 3 × 2 14 95.2
13 × 7 3 × 2 11 93.4
11 × 6 4 × 3 9 81.8
8 × 5 4 × 3 9 70.0
11 × 10 2 × 2 6 96.4
Figure 1 A 66 year-old woman with the right PAVM (Case 2). A. The pulmonary arteriogram (lateral projection) shows a simple type AVM of
the posterior segment. B. The selective angiogram shows the tortuosity of the terminal feeding artery beyond the normal branch. C. A microcatheter
was advanced as close to as possible to the sac. Following the two oversized 10 mm and 6 mm anchoring bare microcoils, four 6-3 mm hydrogel
microcoils were deployed for filling a short segment of feeding artery. Immediately after embolization, a minimal flow remained in the venous sac.
D. Post embolization angiogram at 20 minutes shows the complete PAVM occlusion. E. The baseline non-contrast CT image shows the venous sac
on the posterior lung surface (arrow). F. The six-month follow-up CT image shows shrinkage of the venous sac (arrow).
Figure 2 A 62 year-old woman with three PAVMs (Case 6). A. The selective angiogram shows the PAVM in the posterior segment. B. The distal
feeding artery was embolized with three 6-4 mm hydrogel microcoils and four additional 3 mm bare platinum microcoils. C. Selective angiogram of
the small PAVM in the superior segment shows the tortuosity of the distal feeding artery. D. Because of microcatheter instability, six 4-3 mm 0.014-inch
bare detachable microcoils alone were deployed. Post embolization angiogram shows the feeding artery occlusion. E. After two months, the follow-up
pulmonary arteriogram was obtained in the second session to treat the PAVM in the right lung (not shown). The PAVM in the posterior segment
treated by hydrogel microcoils remained occluded, whereas the smaller PAVM in the superior segment treated by bare microcoils alone shows
recanalization (arrow). F. Selective angiogram reveals the recanalization through the coil interstices. Four additional 3 mm bare microcoils were packed
proximally to achieve complete occlusion (not shown). G. The baseline non-contrast CT image shows the venous sac (arrow) and the draining vein of
the PAVM in the posterior segment (arrowhead). H. The eleven-month follow-up CT shows shrinkage of the venous sac (arrow) and normalization of
the draining vein size (arrowhead).
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2002; Greben et al. 2013). However, such soft and thin
bare platinum detachable microcoils are susceptible for re-
canalization. Indeed, in our series, one small lesion treated
by bare platinum microcoils alone showed early recana-
lization in two months. In the literatures, recanalization
after successful embolization has been the main cause
for reperfusion of PAVMs (Pollak et al. 2006; Milic et al.
2005). The reported recanalization rates were up to 20%
of PAVMs treated with coils (Pollak et al. 2006; Milic
et al. 2005) and 5 to 10% of PAVMs treated with AVPs
(Trerotola & Pyeritz 2010; Fidelman et al. 2008), pos-
sibly through the coil interstices or plug meshes. The
technical reason for recanalization may be inadequate
cross-sectional occlusion with a fewer number of de-
vices or those of inappropriate size than desired (Milic
et al. 2005). Therefore, dense cross-sectional occlusion
by filling the coil interstices is one of the solutions to
enhance the packing density.
The main advantage of hydrogel microcoils is to in-
crease the packing density by hydrogel expansion among
the coil interstices and to establish tight mechanical vessel
occlusion without the aid of thrombus formation. These
features may be helpful in the embolization procedure like
for PAVMs under systemic heparinization. However, there
have been few reports describing application of hydrogel
microcoils for PAVM embolization. In an early report of
peripheral application of hydrogel microcoils, the coils
were deployed through the existing coil mesh in a partially
recanalized PAVM (Nambiar et al. 2008). The additional
increase in volume after hydrogel swelling helped to
achieve complete occlusion of the PAVM. In other re-
ported indications, hydrogel microcoils reduced the coil
numbers when compared with fibered microcoils in
prophylactic embolization of the gastroduodenal artery
before yttrium-90 radioembolization for liver cancers
(Maleux et al. 2013). In another comparison study for
intracranial aneurysms, the higher packing density, shorter
total coil length, and lower recanalization rates were
proven in the hydrogel microcoil group than in the bare
coil group (White et al. 2011). The study suggested that
hydrogel microcoils constitute at least 50% of the total coil
length for <10 mm aneurysms, and at least two thirds of
the total coil length for >10 mm aneurysms. In our series,
the median proportion of hydrogel microcoils was
66.7% of the total coil length. However, there has been
no report yet about the optimal proportion of hydrogel
microcoils to decrease the recanalization rates of
PAVMs. Although the significant sac shrinkage was ob-
tained in our series in the short period up to eighteen
months, longer-term follow-up is necessary to ensure
the sac involution or freedom from symptoms, as reper-
fusion can occur in once resolved PAVMs even after
more than two years (Milic et al. 2005).There were some disadvantages in the hydrogel coils.
We occasionally experienced slight resistance in the coil
delivery, and the microcatheter kicking-back, although
no coil resulted in the catheter stuck or malposition in
the target vessel. Because of the relatively high coil rigid-
ity, adequate support by a deeply inserted guiding cath-
eter and the use of braided microcatheter was important
for controlled delivery of the hydrogel microcoils. High-
flow type microcatheters with inner-diameter 0.027 inch
would be also helpful for better passage of the hydrogel
microcoils. In addition, the limited reposition time within
three minutes was stressful for operators, but all hydrogel
microcoils could be deployed within two minutes that
allowed one or two times attempts of coil reposition. In
our early experience, we waited for full hydrogel expan-
sion up to 20 minutes after the last hydrogel coil was de-
ployed. The progressive vessel occlusion was observed in
five of eight lesions even under systemic heparinization.
There are several limitations in our study. First, this is
a retrospective short-term observational study with a
small number of patients. Second, only 0.018-inch
hydrogel microcoils were evaluated in PAVMs with rela-
tively small feeding arteries, as 0.035-inch hydrogel coils
were not yet available in our country. Third, contrast-
enhanced CT scan was not performed in our series, thus
reperfusion of PAVM could not be precisely assessed.
However, the marked shrinkage of venous sac was good
indicator for efficacy of embolization even on plain CT
images. Forth, it still remains unclear if combining
the hydrogel microcoils can reduce the total coil number
or the recanalization rates in PAVM embolization. Cost-
effectiveness should be also considered, as the hydrogel
microcoils are more expensive than other coils in our
country. Therefore, a further study would be necessary
to prove the true advantage of combining hydrogel
microcoils over conventional coils alone by a random-
ized controlled trial. For larger feeding arteries where
the regular guiding-coaxial catheters are accessible, the
terminal feeder occlusion using 0.035-inch fibered coils
with or without combining AVPs may remain the suit-
able procedure.
In conclusion, the hydrogel microcoils were safely and
effectively applied for occluding PAVMs with relatively
small feeders. The substantial sac shrinkage was obtained
in all treated PAVMs. Further study will be needed to con-
firm if hydrogel microcoils reduce the recanalization rates.
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